Something clarified for me in the Q&A was that the P2 trial isn't going to "double" as a registration study; they are hoping to run P2 and RS "in parallel.
That implies they will have separate cohorts of patients.
Something clarified for me in the Q&A was that the P2 trial...
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.23M | |||
| Open | High | Low | Value | Volume |
| 4.4¢ | 4.5¢ | 4.3¢ | $17.65K | 400.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 152297 | 4.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.5¢ | 369987 | 3 |
View Market Depth
| Last trade - 16.10pm 16/05/2024 (20 minute delay) ? |
|
|||||
|
Last
4.5¢ |
Change
0.000 ( 2.27 %) |
||||
| Open | High | Low | Volume | ||
| 4.3¢ | 4.5¢ | 4.3¢ | 256512 | ||
| Last updated 15.39pm 16/05/2024 ? | |||||
| PTX (ASX) Chart |